Identifies WDR4 as a prognostic biomarker in hepatocellular carcinoma, suggesting its role in guiding immunotherapy.
WDR4 shows elevated expression in HCC tissues and is associated with immune infiltration, establishing it as a prognostic biomarker in HCC. Furthermore, the positive correlation observed between WDR4 and CD68, as well as PD-L1 (CD274), underscores its potential as a guiding factor in immunotherapeutic approaches for HCC.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: